- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 8 residues within 4Å:- Chain A: A.163, Q.164, N.165, R.201, N.246
- Chain F: I.217, G.218
- Ligands: NAG-NAG-BMA-MAN.1
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 7 residues within 4Å:- Chain F: A.163, N.165, R.201, N.246, S.247, T.248
- Chain G: I.217
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 7 residues within 4Å:- Chain G: N.285, N.296, V.297, N.298, R.299, Y.308, E.398
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:R.299, G:R.299
NAG-NAG.7: 2 residues within 4Å:- Chain G: N.63, R.92
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 9 residues within 4Å:- Chain A: I.217
- Chain G: A.163, Q.164, N.165, R.201, N.246, S.247, T.248
- Ligands: NAG-NAG-BMA-MAN.9
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10: 4 residues within 4Å:- Chain A: N.22
- Chain C: G.26, G.27, F.28
Ligand excluded by PLIPNAG.11: 4 residues within 4Å:- Chain A: N.38, T.40, T.318, L.381
Ligand excluded by PLIPNAG.12: 1 residues within 4Å:- Chain A: N.483
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain A: Q.132, N.133
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain A: N.63, N.94
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain F: N.483
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain F: N.38, T.40, T.318, L.381
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain E: G.26, G.27, F.28
- Chain F: N.22
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain F: Q.132, N.133
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain F: N.63
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain F: N.45, N.285, V.297, N.298
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain B: G.26, G.27, F.28
- Chain G: N.22
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain G: N.38, T.40, T.318, L.381
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain G: N.483
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain G: Q.132, N.133
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain G: N.126
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Maurer, D. et al., Influenza A virus Hemagglutinin H3/Darwin/6/2021 in complex with Fab ADI-85666. To be Published
- Release Date
- 2024-11-13
- Peptides
- Hemagglutinin: AFG
ADI-85666 Fab heavy chain: BCE
ADI-85666 Fab light chain: DHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
GG
HB
BC
CE
ED
DH
II
J
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Maurer, D. et al., Influenza A virus Hemagglutinin H3/Darwin/6/2021 in complex with Fab ADI-85666. To be Published
- Release Date
- 2024-11-13
- Peptides
- Hemagglutinin: AFG
ADI-85666 Fab heavy chain: BCE
ADI-85666 Fab light chain: DHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
GG
HB
BC
CE
ED
DH
II
J